Get the Stockscreener App
1.75
5.42%
0.09
After Hours:
1.75
Onconetix Inc stock is traded at $1.75, with a volume of 22,053.
It is up +5.42% in the last 24 hours and down -32.04% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$1.66
Open:
$1.66
24h Volume:
22,053
Relative Volume:
0.46
Market Cap:
$2.72M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.0161
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
+22.38%
1M Performance:
-32.04%
6M Performance:
-62.37%
1Y Performance:
-97.06%
1-Day Range:
$1.66
$1.88
1-Week Range:
$1.41
$1.88
52-Week Range:
$1.37
$88.40
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
1.75 | 2.58M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Onconetix Inc Stock (ONCO) Latest News
Technical Charts Suggest Momentum Shift in Sonata Software LimitedMACD Histogram Signals & Discover Your Financial Freedom Formula - earlytimes.in
Published on: 2026-01-03 01:07:36 - moha.gov.vn
What drives Onconetix Inc J4T stock priceGeopolitical Risk Analysis & Free Explosive Portfolio Gains - earlytimes.in
Financial Review: Pulmatrix (NASDAQ:PULM) and Onconetix (NASDAQ:ONCO) - Defense World
Onconetix faces Nasdaq delisting over share price rule - MSN
Sentiment Watch: What dividend safety score for GBTG stockJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - moha.gov.vn
Is Onconetix Inc. stock trading at a premium valuationSector-Based Investing & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
Why Onconetix Inc. (J4T) stock signals breakout potential2025 Historical Comparison & Expert Approved Momentum Ideas - Улправда
Will Onconetix Inc. stock maintain growth storyMarket Activity Recap & Daily Profit Focused Stock Screening - Улправда
Onconetix settles with IQVIA, adjusts accounts payable - MSN
Is Onconetix Inc. (J4T) stock undervalued at current priceEarnings Overview Summary & Verified Swing Trading Watchlist - Улправда
Published on: 2025-12-20 23:06:18 - moha.gov.vn
Earnings Report: How dovish Fed policy supports Onconetix Inc. (J4T) stockJuly 2025 EndofMonth & Weekly Return Optimization Plans - Улправда
Is Onconetix Inc. stock positioned well for digital economyWeekly Market Summary & High Conviction Buy Zone Alerts - Улправда
Onconetix (NASDAQ: ONCO) details 29.8M-share resale, PIPE dilution and going concern risk - Stock Titan
What Wall Street predicts for Onconetix Inc. stock pricePortfolio Return Summary & Real-Time Market Sentiment Reports - Улправда
Is Onconetix Inc. stock supported by strong fundamentalsBull Run & Weekly High Potential Alerts - Улправда
Can Onconetix Inc. stock hit analyst price targetsShare Buyback & Stepwise Trade Signal Implementation - DonanımHaber
Can Onconetix Inc. stock reach $100 price target2025 Macro Impact & Safe Swing Trade Setup Alerts - DonanımHaber
How Onconetix Inc. (J4T) stock expands through international marketsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
Will Onconetix Inc. stock benefit from commodity pricesEarnings Miss & Weekly High Potential Stock Alerts - Улправда
Insider Buy: Will Onconetix Inc. stock maintain growth storyQuarterly Risk Review & Verified Swing Trading Watchlist - Улправда
Winners Losers: Is Onconetix Inc stock affected by interest rate hikesTrade Risk Summary & Low Risk Investment Opportunities - moha.gov.vn
History Review: Why Onconetix Inc. (J4T) stock signals breakout potentialWeekly Gains Report & Free Community Supported Trade Ideas - moha.gov.vn
Onconetix Inc Stock Analysis and ForecastTop Performing Stocks & Backtest Your Strategy Before You Risk Money - earlytimes.in
Onconetix, Inc. (ONCO) director discloses zero share ownership as of December 5, 2025 - Stock Titan
Onconetix amends license agreement with Labcorp - MSN
Onconetix Approves CEO Bonus and Stockholder Proposals - TipRanks
Onconetix Amends License Agreement with Labcorp - TipRanks
Guidance Update: Why Onconetix Inc J4T stock signals breakout potentialWeekly Stock Recap & Growth Oriented Trade Recommendations - BỘ NỘI VỤ
Is Onconetix Inc. (J4T) stock worth holding before Fed meetingOil Prices & Verified Technical Signals - Newser
Will Onconetix Inc. (J4T) stock enhance shareholder valueWeekly Trade Summary & Community Consensus Picks - Newser
Is Onconetix Inc. (J4T) stock supported by strong fundamentals2025 Valuation Update & Long Hold Capital Preservation Tips - Newser
Is Onconetix Inc. (J4T) stock resilient in recession scenarios2025 Investor Takeaways & Real-Time Chart Breakout Alerts - Newser
Why pension funds invest in Onconetix Inc. (J4T) stockTrade Volume Report & AI Driven Stock Reports - Newser
What insider purchases suggest about Onconetix Inc. (J4T) stockJuly 2025 Trends & Safe Capital Growth Plans - Newser
Can Onconetix Inc. (J4T) stock sustain margin levelsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Onconetix, Inc. (ONCO) -6.5% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Total debt per share of Onconetix Inc – MUN:J4T - TradingView
Working capital per share of Onconetix Inc – MUN:J4T - TradingView
Oncopeptides announces the Nomination Committee - MarketScreener
ONCO SEC FilingsOnconetix 10-K, 10-Q, 8-K Forms - Stock Titan
Can you recover from losses in Onconetix Inc.2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Will Onconetix Inc. (J4T) stock announce special dividendSell Signal & Daily Growth Stock Investment Tips - newser.com
Will Onconetix Inc. (J4T) stock profit from fiscal stimulus2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Tools to assess Onconetix Inc.’s risk profileJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):